On October 24, 2025, the Government of the Russian Federation submitted to the State Duma of the Russian Federation Draft Law No. 1050649-8 " On Amendments to the Federal Law "On Investment Partnerships "(hereinafter - the "IP Law") and Fundamentals of Legislation of the Russian Federation on Notaries" (hereinafter - the "Bill").

The new review of the most notable patents disputes in Life Sciences in Russia and CIS.

• pdf, 10.81 Mb

Stricter score criteria for EV chargers and converters begin in 2026, followed by new rules for Russian bearings in machine tools from July 2026.

The Digital Personal Data Protection Rules, 2025 (“DPDP Rules”), have now been notified and the same has been passed qua the Digital Personal Data Protection Act (DPDP Act), 2023.

Partner and Head of the Lidings’ Intellectual Property practice Boris Malakhov will take part in an annual conference entitled Intellectual Property - 2025 organized by Pravo.ru. The conference will take place on 21 November 2025 in Baltschug Kempinski.

The final of the annual All-Russian competition for court battles and public speaking, the Kutafin Legal Cup, will be held on November 15 at the O.E. Kutafin Moscow State Law University (MSAL).

It is a particular honor for us to curate the Pharmaceutical Law track - an area in which we possess deep practical expertise.

On October 22nd, an online discussion will take place, focusing on the operations of Russian businesses in the Middle East and North Africa (MENA) countries under sanctions pressure. The event is organized by the Legal Insight magazine and the Russian Export Center.

Dmitry Kirillov, Partner, Head of Tax and Customs practice at Lidings, will moderate the discussion session "Disputes with Tax Authorities or Defense in Tax Disputes".

Currently, the efforts of state authorities in the fields of pharmaceuticals and healthcare are also aimed at implementing the Strategy for the Development of the Pharmaceutical Industry of the Russian Federation for the Period up to 2030 (hereinafter referred to as the “Pharma 2030 Strategy”). One of the goals of the Pharma 2030 Strategy is to increase the share of domestically produced medicinal products in the total consumption volume from 61.8% to 66.6% by 2030. In this regard, measures to support Russian medicinal products manufacturers continue to be implemented.